通过ERK/NF-κB通路通过血管素II增加的KCa3.1表达有助于心房纤维化
Zujuan Wang1, Yujie Ren2, Dongmei Zhang1
1Department of Pathology and Pathophysiology, Suzhou Medical College of Soochow University, 199 Ren-ai Road, Suzhou 215123, Jiangsu, China.
Journal of molecular and cellular cardiology
|March 23, 2025
概括
介导体Ca2+激活的K+通道 (KCa3.1) 通过增加纤维细胞的增殖和原蛋白的产生来促进心房纤维化. 抑制KCa3.1可能为心房动相关的纤维化提供一种新的治疗方法.
科学领域:
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心房动 (AF) 与心房纤维化有关,其特征是纤维细胞增殖和细胞外矩阵 (ECM) 重塑.
- 驱动心房纤维化的确切机制,特别是特定离子通道的作用,仍然不清楚.
- 介导体Ca2+激活的K+通道 (KCa3.1) 与各种组织中的纤维化过程有关.
研究的目的:
- 为了研究KCa3.1在 ангиотензинII (AngII) 诱导的心房纤维化中的作用.
- 阐明参与Ang II介导的KCa3.1调节的信号通路.
- 评估针对心房纤维化治疗KCa3.1的治疗潜力.
主要方法:
- 主要大鼠心房纤维细胞/肌纤维细胞被Ang II治疗.
- 评估了KCa3.1表达,细胞增殖和ECM的产生.
- 使用抑制剂和siRNA评估了ERK/NF-κB信号通路的参与;在体内研究中使用Ang II注入的老鼠.
主要成果:
- 在体外,Ang II增加了KCa3.1的表达,纤维细胞的增殖和ECM的产生.
- 这些效应被洛萨坦 (Ang II受体对抗剂) 和TRAM-34 (KCa3.1抑制剂) 显著降低.
- 格II诱导的KCa3.1上调通过ERK/NF-κB通路进行调节;体内,KCa3.1抑制减轻了格II诱导的心房纤维化.
结论:
- 在心房纤维细胞/肌纤维细胞中,Ang II通过ERK/NF-κB通路对KCa3.1进行上调促进心房纤维化.
- 激活KCa3.1导致细胞增殖和原沉积的增加,导致心房纤维化.
- 抑制KCa3.1代表了治疗与AF相关的心房纤维化的一种潜在的治疗策略.
更多相关视频
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
424
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
424
Roles of Electrolytes: Sodium and Potassium
219
Sodium plays a crucial role in maintaining fluid and electrolyte balance and overall bodily homeostasis. Sodium balance is primarily regulated by kidney function, which adjusts sodium elimination to match dietary intake and maintain proper electrolyte levels. Sodium is the most abundant cation in the extracellular fluid (ECF) and is found in salts such as sodium chloride (NaCl) and sodium bicarbonate (NaHCO3). Although cellular plasma membranes are relatively impermeable to sodium, its role in...
219
Regulation of Sodium and Potassium
329
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
329
Antiepileptic Drugs: Potassium Channel Activators
138
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
138
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
867
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
867
Ionic Strength: Effects on Chemical Equilibria
1.3K
The addition of an inert ionic compound increases the solubility of a sparingly soluble salt. For example, adding potassium nitrate to a saturated solution of calcium sulfate significantly enhances the solubility of calcium sulfate. Le Châtelier's principle cannot predict this shift in the equilibrium. Instead, this could be explained in terms of changes in the effective concentration of the ions in solution in the presence of added inert salt.
In this solution, the primary...
In this solution, the primary...
1.3K


